Key Record Dates
ClinicalTrials.gov Identifier: | NCT03033511 |
---|---|
Brief Title: | A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) (MERU) |
First Submitted : | January 25, 2017 |
First Submitted that Met QC Criteria : | January 25, 2017 |
First Posted : | January 26, 2017 (Estimate) |
Results First Submitted : | November 11, 2020 |
Results First Posted with QC Comments : | December 7, 2020 |
Results First Submitted that Met QC Criteria : | December 17, 2020 |
Results First Posted : | December 21, 2020 |
Last Update Submitted that Met QC Criteria : | July 28, 2021 |
Last Update Posted : | July 29, 2021 |